Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00582478 · ClinicalTrials.gov registry record

Investigating Mechanisms to Explain Age Associated Differences in Quality of Life Among Breast Cancer Patients

A clinical trial of Breast Cancer, sponsored by Memorial Sloan Kettering Cancer Center.

Active
Registry status
650
Enrollment target
1
Study location

NCT00582478: Active study of Breast Cancer, sponsored by Memorial Sloan Kettering Cancer Center.

NCT00582478 is a study of Breast Cancer that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 650 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00582478, a study of Breast Cancer, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.

ACTIVE NOT RECRUITING
Registry status
650 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to look at how breast cancer treatment affects quality of life in women of different ages. The U.S. Army Breast Cancer Research Program funds this study. In this research project, we wish to study a woman's quality of life after breast cancer treatment as related to her health. We want to know how you feel about your quality of life.

Conditions Studied

Interventions

  • BEHAVIORAL questionnaires

Study Locations (1)

New York

  • Memorial Sloan-Kettering Cancer Center - New York

Trial Details

FieldValue
Enrollment Target 650 participants
Start Date 2001-10
Est. Completion 2026-12
Memorial Sloan Kettering Cancer Center

1,884 total trials

What the registry record for NCT00582478 still lists

NCT00582478 is an observational study that tracks outcomes without assigning an intervention. The registered 650 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (77% lower).

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which questionnaires is the first listed.

NCT00582478 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT00582478 about?

NCT00582478 is a clinical study titled "Investigating Mechanisms to Explain Age Associated Differences in Quality of Life Among Breast Cancer Patients". The purpose of this study is to look at how breast cancer treatment affects quality of life in women of different ages. The U.S. Army Breast Cancer Research Program funds this study. In this research project, we wish to study a woman's quality of life after breast cancer treatment as related to her ...

What is the current status of trial NCT00582478?

This trial is currently active not recruiting. The enrollment target is 650 participants. The study started on 2001-10. Estimated completion is 2026-12.

What conditions does trial NCT00582478 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT00582478?

The interventions under investigation include: questionnaires (BEHAVIORAL).

Who is sponsoring clinical trial NCT00582478?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00582478 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00582478's enrollment target sits among peer trials

650 168th of 1224 higher than 1,057 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02934477 · 650 participants

    Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis

  • NCT04579120 · 650 participants

    Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)

  • NCT04875702 · 650 participants · Phase 4

    Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout

  • NCT05046600 · 650 participants

    Registry of Arthrex Hand and Wrist Products

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00582478, the US trial registry maintained by the National Library of Medicine. NCT00582478 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.